Novartis Simulect (basiliximab) 20 mg vial
date: label: date made
content: 2014
name: label: maker
content: Novartis Pharmaceuticals Corporation
notes: label: Location
content: Currently not on view
place: label: place made
content: United States: New Jersey, East Hanover
setName: label: See more items in
content: Medicine and Science: Medicine
dataSource: label: Data Source
content: National Museum of American History
identifier: label: ID Number
content: 2014.0186.06
label: accession number
content: 2014.0186
label: catalog number
content: 2014.0186.06
objectType: label: Object Name
content: pharmaceutical
physicalDescription: label: Physical Description
content: cardboard (container material)
label: Physical Description
content: basiliximab (recombinant chimeric, murine/human, monoclonal antibody), 20 mg (drug active ingredients)
label: Physical Description
content: disodium hydrogen phosphate, anhydrous, 0.99 mg (drug active ingredients)
label: Physical Description
content: sodium chloride, 1.61mg (drug active ingredients)
label: Physical Description
content: monobasic potassium phosphate, 7.21 mg (drug active ingredients)
label: Physical Description
content: sucrose, 20 mg (drug active ingredients)
label: Physical Description
content: glycine, 40 mg (drug active ingredients)
label: Physical Description
content: mannitol, 80 mg (drug active ingredients)
label: Measurements
content: overall: 7.3 cm x 9.8 cm x 3.3 cm; 2 7/8 in x 3 27/32 in x 1 5/16 in